After producing α1-3-galactosyltransferase knockout (GKO) pigs, most of the organs of these pigs showed less antigenicity to the human body. However, wild-type adult pig islets (API) that originally contained negligible levels of α-galactosidase now showed a clear antigenicity to human serum. In this study, N-glycans were isolated from both APIs and human islets. Their structures were then analyzed by a mapping technique based on their high-performance liquid chromatography elution positions and matrixassisted laser desorption/ionization-time-of-flight mass spectrometric data. Both preparations contained substantial amounts of high-mannose structures. The N-glycans from human islets were separated into 17 neutral, 8 monosialyl and 4 di-sialyl glycans, and the API glycans were comprised of 11 neutral, 8 mono-sialyl, 3 di-sialyl, 2 monosulfated, 3 mono-sialyl-mono-sulfated and 1 di-sulfated glycans. Among them, the API preparation contained one neutral, five mono-sialyl glycans and six sulfated glycans that were not detected in human islets. The structures of 9 of these 12 could be clearly determined. In addition, a study of the sulfate-depleted API suggests that sulfate residues could be antigenic to humans. The data herein will be helpful for future studies of the antigenicity associated with API.
Introduction
The increasing challenges associated with the worldwide shortage of donor organs have led to a renewed interest in xenotransplantation. The pig pancreas is considered to be the most suitable source of islets for clinical xenotransplantation. Some clinical trials have resumed in New Zealand, Russia, etc., using islets from a wild-type pig via the use of an immuno-isolation technique (Elliott 2011 ). In addition, based on data collected from the "Inventory of human xenotransplantation practices" (http://www.humanxenotransplant.org/index.html), many clinical trials appear to be ongoing.
On the other hand, after producing α1-3-galactosyltransferase knockout (GKO) pigs (Dai et al. 2002; Takahagi et al. 2005) , most of the organs from these pigs were found to show less antigenicity to the human body. However, wild-type adult pig islets (API) that originally contained negligible levels of α-galactosidase (α-Gal) (Galα1-3Gal) (Galili et al. 1987 ) showed a clear antigenicity to human serum (Komoda et al. 2004) , and this fact represents a significant obstacle to successful xenotransplantation (Thompson et al. 2011) .
Concerning the so-called non-Gal epitopes, many studies related to glycoproteins and glycolopids are on-going in attempts to identify them. However, our knowledge of non-Gal glycoantigens is still incomplete. That is, previous analyses of N-glycans from pigs included the use of additional tissues, in addition to islets. However, besides α-Gal and HanganutziuDeicher (Varki et al. 2009; Yamamoto et al. 2013) antigen expression, the glycosylation of API remains relatively unclear (Breimer 2011; Byrne et al. 2011; Miyagawa et al. 2012) .
We wish to report herein on the analysis of the glycosylation of the N-linked sugars of API, compared with the corresponding values for human islets, using a high-performance liquid chromatography (HPLC) technique, which is capable of providing reliable data. The collected data will be of use in future research concerning non-Gal antigens and promises to provide us with clues for producing new types of immuno-modified pigs with less antigenicity than GKO pigs.
Results
Isolation of N-glycans of the porcine and human islets N-glycans derived from porcine (11.9 mg of protein) and human islets (12.47 mg of protein) were separated into five peaks, based on increasing acidity using a diethylaminoethyl (DEAE) column. The following peaks were produced: Neutral (N), Peak 1; mono-sialyl (M), Peak 2; di-sialyl (D) or monosulfate (S1), Peak 3; mono-sialyl-mono-sulfate (MS2), Peak 4 and di-sulfate (S2), Peak 5; glycan fractions with molar ratios ( peak areas) of 84.4, 3.6, 2.6, 2.2 and 7.2% from APIs, and 94.0, 4.0, 2.0, 0 and 0% from the human islets, respectively ( Figure 1 ).
Concerning API, when an octa decyl silyl (ODS) column was used, it was possible to separate the neutral fraction into fractions N1-N9, the mono-sialyl fraction into fractions M1-M6, the di-sialyl or mono-sulfate fraction into fractions D1-D3 and S1, the mono-sialyl-mono-sulfate fraction into fractions MS1-MS3 and the di-sulfate fraction into fraction S2. On the other hand, in the case of human islets, the neutral fraction was separated into N1-N13, the mono-sialyl into M1-M6 and the di-sialyl into D1-D4, as shown in Figure 2A -H.
Further analysis with GALAXY database These ODS fractions were individually fractionated on an amide column and further subjected to matrix-assisted laser desorption/ionization time-of-flight mass spectrometric (MALDI-TOF-MS) analysis. The porcine N2, N6, M2, M3 and S1 and the human N2, N5, N6, N12, M2 and M4 fractions were found to contain two kinds of N-glycans (Figures 3 and 4) .
The coordinates of all of the N-glycans coincided with those for known references in the glycoanalysis by the three axes of MS and chromatography (GALAXY) database except for several N-glycan fractions including human fractions N5-1, N5-2, N6-1, N6-2, M1, M2-2 and porcine S1-1, MS1and MS3. Most of the N-glycan structures were then identified by the mapping technique on the basis of their HPLC elution positions and MALDI-TOF-MS data.
Structural analysis of each sample Pyridylamino (PA)-glycans, which did not correspond to any of the N-glycans so far registered in GALAXY, were trimmed by treatment with an exoglycosidase, which produced known glycans (Yagi et al. 2005) .
In the case of S1-2, no reactivity was detected by β-acethylhexiominidase. Next, a methanolysis treatment induced the conversion of S1-2 into S1-2a, but additional treatment with β-galactosidase resulted in no change to S1-2a. Moreover, the β-N-acethylhexosaminidase treatment converted S1-2a into S1-2b, and S1-2b was proved to be the same structure as M4.1 in GALAXY, as evidenced by the observation that samples of S1-2b and M4.1 co-chromatographed ( Figure 5 ).
The MS2 sample was analyzed following a similar procedure. The sample did not serve as a substrate for β-galactosidase and α2,3-sialydase, but was converted into MS2a by treatment with α-sialydase. Further methanolysis and β-galactosidase converted MS2a into MS2b and MS2c, respectively. MS2b was next verified to be 210.4a in GALAXY by the co-chromatography of both samples. On the other hand, MS2c, when treated with β-Nacethylhexosaminidase andmethanolysis,wasconvertedinto MS2d and MS2e, respectively. MS2e was also proved to be 110.4a in GALAXY by the co-chromatography of both samples ( Figure 6 ).
Concerning S2, the sample was unchanged as a result of a β-N-acethylhexosaminidase treatment. On the other hand, a methanolysis treatment cleaved two sulfate residues from S2 and produced S2a, which was shown to be 210.4b in GALAXY by the co-chromatography of both samples (Figure 7) .
In the analyses, a total of 28 and 29 N-glycan structures of API and human islets, respectively, were identified and the findings are summarized in Tables I-VI (Supplementary data, Figure S1 ).
Sodium chlorate treatment on pig islets
The effect of removal of the sulfate structures of pig islets on the antigenicity to human serum was investigated. The use of a sodium chlorate and a sulfate-free medium led to a significant reduction in antigenicity to human serum, suggesting that the sulfate structures in adult islets are targets for human natural antibodies (Figure 8 ).
Discussion
Twenty-eight kinds of N-linked glycans were identified in the case of the API glycans and 29 were identified from human islets, based on their HPLC elution peaks. While the human preparation contained neutral, mono-sialyl, di-sialyl N-linked glycans, the API sample contained not only these three types, but mono-sulfate, MS2 and di-sulfate types of N-linked glycans as well. Among them, one neutral, five mono-sialyl and six sulfates of N-linked glycans in the API preparation were not detected in human islets. The structures of 9 of these 12 glycans were clearly identified in this study.
Concerning the characteristics of the N-glycans identified in the API preparation, the neutral glycans contained relatively high levels (%) of high-mannose type glycans. In comparison with the N-glycans from human islets, the high-mannose type of N-glycan found in API contains high levels (5 or 6) of mannoses. In addition, glycans with structures of fractions N6-2 were not detected in human islets. On the other hand, in the case of API, the relative content of sulfated N-glycans approached 10%. In addition, the di-sulfate type glycans represented 7% of the relative quantity, indicating that sulfated N-glycans are a common structure in N-glycans of API but do not appear to be produced by human islets. In addition, all the sulfates are attached to a β-linked N-acetylgalactosamine (GalNAc). No terminal fucose was detected in the N-glycans from either type of islets in this study.
Previous studies reported by other groups concluded that many kinds of N-glycans are found in API, using MALDI-TOF/ MS and MS/MS (Kim, Gil et al. 2008; Kim, Gil et al. 2009; . The difference in the number of detected N-glycans in this study can be attributed to the sensitivity of the MS method and HPLC. It, thus, appears that the accuracy of the data presented here using HPLC mapping in conjunction with a MALDI-TOF technique provided much more detailed information. That is, MS data are sensitive and can be rapidly obtained, but indicate only a glycan structure based on the calculated molecular weight. Therefore, discriminating between isomeric structures becomes difficult (Wheeler and Harvey 2001) . In addition, except for N-glycolylneuraminic acid (NeuGc), it does not indicate the specific structure of sialyl acids present. On the other hand, the data reported herein can be used to identify the representative features of each N-glycan in the API preparation. However, the possibility that several glycans, such as pN6-2, pM2-1, pM2-2, pM3-1, pM3-2 and pM5, that were not detected in humans islets as major N-glycans are expressed in human islets at very low levels cannot be completely excluded. In addition, concerning the sulfated N-glycans such as S1-1, S1-2, S2, MS1 and MS3, the accuracy in identifying the position of the SOH3 attached to β1-4GalNAc was not clear in this study, and it is possible that these sulfated glycans also may be produced in human islets or other tissues, because humans produce several sulfotransferase enzymes that can catalyze the attachment of a sulfate to GalNAc (Boregowda et al. 2005) .
Chlorate is a selective inhibitor of adenosine triphosphate sulfate adenylyltransferase, the first enzyme in the sulfate activation pathway (Girard et al. 1998) . It inhibits all sulfotransferases. Therefore, although API had a diminished antigenicity to human serum, especially IgM, as a result of the presence of sodium chlorate treatment, a structural analysis of the changes on the sulfated N-glycans and other nonsulfated glycans of the API after the treatment might be needed to assess antigenicity issues. On the other hand, it was not possible to determine the binding site of the sulfate residue to GalNAc using this method. However, the possibility that the sulfate residue is one of the non-Gal antigens in pig islets cannot be excluded based on the data presented herein. Further study will be needed to analyze the non-Gal antigen in pig islets, especially to sulfotransferase enzymes.
In comparison with a report concerning the pig lung and trachea, using exactly the same HPLC mapping in conjunction with the MALDI-TOF technique, Sriwilaijaroen et al. (2011) reported a relatively small percent of high-mannose type N-glycans of porcine islets N-glycans. However, in this study, pig islets contain a relatively large percent of N-glycans, 81%, and human islets also contain 76.7%. Therefore, this evidence related to high-mannose types was assumed to be a typical feature of islets. It is noteworthy that in this pig islets study no evidence was found for the presence of α-Gal and NeuGc structures, while the pig lung and trachea clearly produce both antigens. Concerning α-Gal, as has been indicated in many reports, pig islets express very low levels of α-Gal. On the other hand, concerning NeuGc, our previous study reported that NeuGc is expressed on the N-glycans of API (Komoda et al. 2004) . Therefore, pig islets must contain NeuGc in relatively minor amounts and, as a result, were not detected in this study, because pig lung and trachea contain relatively minor levels of NeuGc structures.
In addition, NeuGc-Gal-GlcNAc and Galα1-3 Lewis x (Lew x ) were recently reported as novel antigens, as evidenced by a structural analysis of N-glycans from the miniature pig kidney (Kim et al. 2006) . However, neither of these antigens was detected in this study. Blixt et al. (2009) reported on the carbohydrate specificities of sera obtained from clinical patients in whom neonatal bone pig islet-like cell clusters (NPCC) had been intraportally injected, using a printed covalent glycan array with 200 structurally defined glycans. Besides α-Gal and NeuGc, the patients had Abs against terminal α-linked GalNAc, β3-linked Gal especially Galβ1,3GlcNAc even if terminally sulfated or sialylated, β-GlcNAc except for β1,3-linked, oligomannosyl compounds, some neuranimic acid (NeuAc) and Galα1-3Lew x . Compared with the data reported here, pM5 has β-GlcNAc, might be applicable for the target structure of the patients. In addition, N6-2, pM2-2 and pM3-2, which contain Manα1-3Manα1-6Man structures, are also potential target antigens. However, the antigenicity of NPCC may slightly be different from that for API.
As the other non-Gal antigens, the Forssman, the terminal GalNAc related to the Tn-antigen (GalNAcα-O-Ser/Thr), Tantigen (Thomsen-Friedenreich; Galβ 3GalNAcα-O-Ser/Thr) and sialyl-Tn antigen (NeuAcα2,6GalNAcα-O-Ser/Thr) are also reported to be important (Ezzelarab et al. 2005) . However, these glycans are related to O-glycans and glicolipids (Diswall et al. 2011) .
In summary, as a feature, pig islets are rich in high-mannose type N-glycans, especially relatively low amounts of mannose. Several API structures, such as N6-2, pM2-1, 2-2, 3-1, 3-2, and pM5, and the sulfate structure, β-linked GalNAc-SOH3, were not detected in human islets. In addition, it is possible that the sulfated glycans of API are involved in the observed antigenicity to human serum. The data herein provide important information that can be useful to future clinical xenotransplantation studies. Fig. 5 . Structural analysis of S1-2. (A) ODS peak after methanolysis treatment of S1-2. Peak 1 is the nonreacted sample, S1-2 (7.5 GU and 1641 Da). Peak 2 corresponds to S1-2a (8.3 GU and 1557 Da). (B) ODS peak after β-galactosidase treatment to S1-2a. Peak 3 is identical to S1-2a in ODS (GU) and molecular weight. (C) ODS peak after β-N-acetylhexosaminidase treatment of S1-2a. Peak 4 corresponds to S1-2b (7.5 GU and 1151 Da). (D) ODS peak after co-chromatography of S1-2b and M4.1. S1-2b was then proved to be the same structure as M4.1 in GALAXY. (E) ODS peak after β-galactosidase treatment to S1-2. Peak 6 is just the same as S1-2 in GU and molecular weight. * Not a sugar.
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Materials and methods
Pig islet isolation
Pancreatic glands were removed from several pigs at a slaughterhouse that handles young market weight pigs (Large White/ Landrace x Duroc, 6 months old, 100 kg). Isolation of porcine islets was performed using the Islet Isolation Technique (Goto et al. 2004) , with minor modifications. Purified islet fractions were pooled and cultured at 37°C in a humidified atmosphere with 5% CO 2 in CMRL1066 medium (Biochrom, Berlin, Germany) supplemented with 20% heat inactivated porcine serum, 2 mm N-acetyl-L-alanyl-L-glutamine, 10 mM N-2-hydroxyethylpiperazine-N1-2-ethanesulfonic acid, 100 IU/mL penicillin, 100 µg/mL streptomycin (Biochrom) and 20 µg/mL ciprofloxacin (Bayer, Leverkusen, Germany).
Human islet isolation
The method used to isolate islets has been reported previously (Matsumoto et al. 2002) . In brief, the pancreas was distended with a cold enzyme solution through the pancreatic duct using a pressure-controlled pump system. In all cases, the distended pancreata were digested using the semi-automated method (Matsumoto et al. 2006 ). All centrifuged pellets were collected in cold storage/purification stock solution (Mediatech, Inc., Manassas, VA).
Islet isolations were conducted based on the Edmonton protocol with our modifications. The results of the isolations were evaluated based on the Edmonton protocol. Islets were purified with a COBE 2991 cell processor (CaridianBCT, Inc., Lakewood, CO) using density-adjusted iodixanol-based continuous density gradient. The final preparation of islets was assessed using dithizone staining (Sigma Chemical Co., St. Louis, MO) for islet yield and purity. Islet yield was converted into a standard number of islet equivalents (diameter standardizing to 150 µm). Islet viability was evaluated with fluorescein diacetate (10 µmol/L) and propidium iodide (15 µmol/L) staining. All procedures were done at the Baylor Research Institute, TX. . Structural analysis of MS2. (A) ODS peak after α2,3-sialidase treatment to MS2. Peak 1 was just the same as MS2 in GU and molecular weight. (B) ODS peak after α-sialidase treatment to MS2. Peak 2 corresponds to MS2a (12.1 GU and 1988 Da). (C) ODS peak after methanolysis treatment to MS2a. Peak 3 is the nonreacted sample. Peak 4 lacked one sulfate residue from MS2a and corresponds to MS2b (13.9 GU and 1907 Da). (D) ODS peak after co-chromatography of MS2b and 210.4a in GALAXY. MS2b was proved to be the same structure as the 210.4a in GALAXY. (E) ODS peak after β-galactisidase treatment to MS2a. Peak 6 lacked one galactose from MS2a and corresponds to MS2c (11.4 GU and 1826 Da). (F) ODS peak after β-N-acetylhexosaminidase treatment to MS2c. Peak 7 corresponds to MS2d (9.7 GU and 1622 Da). (G) ODS peak after methanolysis treatment of MS2d. Peak 8 was the nonreacted sample. Peak 9 lacked one sulfate residue from MS2d and corresponds to MS2e (11.0 GU and 1541 Da). (H) ODS peak after co-chromatography of MS2e and 110.4a in GALAXY. MS2e was proved to be the same structure as the 110.4a in GALAXY. (I) ODS peak after β-galactisidase treatment to MS2. Peak 11 is identical to MS2 in GU and molecular weight. * Not a sugar.
N-glycans of porcine islets
Materials for analyses
Glycoamidase A from sweet almond, α-manosidase, β-galactosidase and β-N-acetylhexosaminidase from jack bean were purchased from Seikagaku Kogyo Co. (Tokyo, Japan). α-Gal from coffee bean was purchased from Oxford GlycoSciences, Inc. (Oxford, UK). Trypsin and chymotrypsin were obtained from Sigma (St. Louis, MO). Pronase protease from Streptomyces griseus was from Calbiochem (San Diego, CA). The PA derivatives of isomalto-oligosaccharides 4-20 (indicating the degree of polymerization of glucose residues) and reference PAoligosaccharides were purchased from Seikagaku Kogyo Co.
Characterization of N-glycan derived from islets
The residue after extracting each islet with a chloroform-methanol solution was used as the starting material. All experimental procedures used, including the chromatographic conditions and glycosidase treatments, have been described previously (Takahashi et al. 2001) . The extract was proteolyzed with chymotrypsin and trypsin mixture and further digested with glycoamidase A to release N-glycans. After the removal of the peptide materials, the reducing ends of the N-glycans were derivatized with 2-aminopyridine (Wako, Osaka, Japan). This mixture was applied to a DEAE column (Tosoh, Tokyo, Japan) or a TSK-gel Amide-80 column (Tosoh), and each fraction that was separated on the amide column was applied to a Shim-pack HRC-ODS column (Shimadzu, Kyoto, Japan). The elution times of the individual peaks onto the amide-silica and ODS columns were normalized with respect to a PA-derivatized isomalto-oligosaccharide with a known degree of polymerization, and are represented in units of glucose unit (GU). Thus, a given compound from these two columns provided a unique set of GU values, which corresponded to the coordinates of the two dimension HPLC map. The PA-oligosaccharides were identified by comparison with the coordinates of <500 reference PA-oligosaccharides in a homemade web application, GALAXY (http://www.glycoanalysis.info/) (Takahashi and Kato 2003) . The calculated HPLC map based on the unit contribution values was used to estimate some highmannose type PA-oligosaccharides. The PA-oligosaccharides were co-chromatographed with the reference to PA-oligosaccharides on the columns to confirm their identities.
MS analyses of PA-glycans PA-oligosaccharides were subjected to MALDI-TOF-MS analysis. The matrix solution was prepared as follows: 10 mg of 2,5-dihydroxybenzoic acid (Sigma) was dissolved in 1:1 (v/v) of acetonitrile/water (1 mL). Stock solutions of PA-glycans were prepared by dissolving them in pure water. One microliter of sample solution was mixed on the target spot of a plate with 1 μL of matrix solution and then allowed to air-dry. MALDI-TOF-MS data were acquired in the positive modes using AXIMA-CFR (Shimadzu) operated in the linear mode.
Single islet cell preparation Single-cell suspensions were prepared by the method described by Ono et al. (1977) . Isolated islets were exposed to 0.04% ethylenediaminetetraacetic acid for 5 min at room temperature Units of GU were calculated from the elution times of the peaks obtained from the ODS column in Figure 2 and the Amide column in Figure 3 Units of GU were calculated from the elution times of the peaks obtained from the ODS column in Figure 2 and the Amide column in Figure 3 
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and collected by centrifugation at 400 × g for 1 min. The islets were then suspended in 4 mL of 1000 PU/mL Dispase-II (Godo-Shusei Co. Tokyo, Japan) and treated at 37°C for 15 min. Cell aggregates were allowed to settle and the supernatant was transferred to a conical tube. The pooled harvests were centrifuged at 400 × g for 3 min. The cell pellet was washed twice with phosphate buffer saline (PBS) and re-suspended in PBS.
Flowcytometry
The islets were incubated with a 10% solution of normal human pooled serum (NHS) at 4°C for 1 h, washed and then incubated with 1.25 µg of fluorescein isothiocynate-conjugated anti-human IgG and IgM (Cappel, West Chester, PA) as a second antibody for 1 h at 4°C. The stained cells were analyzed with a FACS Calibur flow cytometer (Nippon Becton Dickinson, Tokyo, Japan).
Sulfate-depleted cells
Islets were starved for 24 h in sulfate-free RPMI1640 medium containing 1% of fetal cow serum supplemented with fresh 10 mM sodium chlorate (Nakarai Tesque, Kyoto, Japan).
Supplementary data
Supplementary data for this article are available online at http:// glycob.oxfordjournals.org/. Units of GU were calculated from the elution times of the peaks obtained from the ODS column in Figure 2 and the Amide column in Figure 3 . Figure S1 ). 
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